article thumbnail

European authorities recognised for leading medicine regulatory oversight

European Pharmaceutical Review

The agencies holding this status have been approved and validated as compliant and committed to upholding the “highest level of regulatory standards and practices for quality, safety and efficacy of medicines and vaccines ”.

article thumbnail

Big Pharma leading in access-to-medicine strategies, shows data

European Pharmaceutical Review

To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. Novartis signed the first licence for a non-communicable disease (NCD) product, a leukaemia medicine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Is digital the future of medicine?

World of DTC Marketing

Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. A study of some 16m American ones just reported in jama Internal Medicine , a journal, found that their use of telemedicine surged 30-fold between January and June. ” Digital medicine also needs better clarification.

Medicine 201
article thumbnail

Ex-Ironwood CEO Mark Mallon pops up at George Medicines

pharmaphorum

George Medicines has appointed former Ironwood CEO Mark Mallon to lead the company as it tries to get its triple therapy for hypertension over the finish line.

Medicine 105
article thumbnail

Pfizer sets up DTC marketing platform as Q1 sales beat expectations

Fierce Pharma

Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen. Following the lead of Eli Lilly, Pfizer will establish a direct-to-consumer service, selling some of its medicines online and avoiding industry middlemen.

Marketing 280
article thumbnail

NICE recommends first medicine for severe alopecia areata

European Pharmaceutical Review

This is “an important milestone” according to Lynn Clay, Specialty Care Lead at Pfizer UK. However, on 31 October 2023, a marketing authorisation in Great Britain was granted for the medicine ritlecitinib. “It The post NICE recommends first medicine for severe alopecia areata appeared first on European Pharmaceutical Review.

article thumbnail

What is the future of biologic medicines?

European Pharmaceutical Review

Two trends that I expect to continue in the foreseeable future are the move towards precision medicine and the diversification of the biologics chemical structures. There have been upward of 1,900 precision medicine clinical trials conducted to date. Available from: [link] The post What is the future of biologic medicines?

Medicine 105